Description
EMPA Q 25mg tablets offer powerful and comprehensive management for adults with type 2 diabetes. Each tablet contains 25mg of Empagliflozin, a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor. This advanced medication works by helping your kidneys remove excess glucose from your bloodstream through your urine, leading to reduced blood sugar levels. Beyond its primary role in glycemic control, EMPA Q 25mg is also indicated to significantly lower the risk of cardiovascular death, hospitalization for heart failure, and the progression of chronic kidney disease in relevant adult patients. Taken once daily, with or without food, it forms a crucial part of a holistic diabetes care plan, alongside a healthy diet and regular exercise.
